Fabrication of polymeric scaffolds with a controlled distribution of pores

被引:28
作者
Capes, JS
Ando, HY
Cameron, RE
机构
[1] Univ Cambridge, Dept Mat Sci & Met, Pfizer Inst Pharmaceut Mat Sci, Cambridge CB2 3QZ, England
[2] Pfizer Inc, Pfizer Global Res & Dev, Ann Arbor Labs, Ann Arbor, MI USA
关键词
D O I
10.1007/s10856-005-4708-5
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The design of tissue engineering scaffolds must take into account many factors including successful vascularisation and the growth of cells. Research has looked at refining scaffold architecture to promote more directed growth of tissues through well-defined anisotropy in the pore structure. In many cases it is also desirable to incorporate therapeutic ingredients, such as growth factors, into the scaffold so that their release occurs as the scaffold degrades. Therefore, scaffold fabrication techniques must be found to precisely control, not only the overall porosity of scaffolds, but also the pore size, shape and spatial distribution. This work describes the use of a regularly shaped porogen, sugar spheres, to manufacture polymeric scaffolds. Results show that pre-assembling the spheres created scaffolds with a constant porosity of 60%, but with varying pores sizes from 200-800 mu m, leading to a variation in the surface area and likely degradation rate of the scaffolds. Employing different polymer impregnation techniques tailored the number of pores present with a diameter of less than 100 mu m to suit different functions, and altering the packing structure of the sugar spheres created scaffolds with novel layered porosity. Replacing sugar spheres with sugar strands formed scaffolds with pores aligned in one direction. (C) 2005 Springer Science + Business Media, Inc.
引用
收藏
页码:1069 / 1075
页数:7
相关论文
共 26 条
[1]   The effects of molecular weight and porosity on the degradation and drug release from polyglycolide [J].
Braunecker, J ;
Baba, M ;
Milroy, GE ;
Cameron, RE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 282 (1-2) :19-34
[2]  
Butler R, 2001, ADV MATER, V13, P1459, DOI 10.1002/1521-4095(200110)13:19<1459::AID-ADMA1459>3.0.CO
[3]  
2-K
[4]   Polymer synthesis and processing using supercritical carbon dioxide [J].
Cooper, AI .
JOURNAL OF MATERIALS CHEMISTRY, 2000, 10 (02) :207-234
[5]   Polyglycolide with controlled porosity: An improved biomaterial [J].
Epple, M ;
Herzberg, O .
JOURNAL OF MATERIALS CHEMISTRY, 1997, 7 (06) :1037-1042
[6]   Non-connected versus interconnected macroporosity in poly (2-hydroxyethyl methacrylate) polymers. An X-ray microtomographic and histomorphometric study [J].
Filmon, R ;
Retailleau-Gaborit, N ;
Grizon, F ;
Galloyer, M ;
Cincu, C ;
Basle, MF ;
Chappard, D .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2002, 13 (10) :1105-1117
[7]   A new approach based on injection moulding to produce biodegradable starch-based polymeric scaffolds: morphology, mechanical and degradation behaviour [J].
Gomes, ME ;
Ribeiro, AS ;
Malafaya, PB ;
Reis, RL ;
Cunha, AM .
BIOMATERIALS, 2001, 22 (09) :883-889
[8]   Preparation and characterization of a highly macroporous biodegradable composite tissue engineering scaffold [J].
Guan, LM ;
Davies, JE .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2004, 71A (03) :480-487
[9]  
HILLIARD JE, 1968, QUANTITATIVE MICROSC, P45
[10]   Supercritical fluid mixing: preparation of thermally sensitive polymer composites containing bioactive materials [J].
Howdle, SM ;
Watson, MS ;
Whitaker, MJ ;
Popov, VK ;
Davies, MC ;
Mandel, FS ;
Wang, JD ;
Shakesheff, KM .
CHEMICAL COMMUNICATIONS, 2001, (01) :109-110